
Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2024 Earnings Call Transcript
Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2024 Earnings Call Transcript March 10, 2025 Coherus BioSciences, Inc. misses on earnings expectations. Reported EPS is $-0.28 EPS, expectations were $-0.1. Operator: Hello everyone and welcome to the Coherus …